XML 22 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 525,540 $ 1,133,537
Short-term marketable debt securities 314,438 35,097
Accounts receivable, net 110,253 88,783
Inventory, net 71,083 61,948
Prepaid expenses and other current assets, net 33,800 27,741
Total current assets 1,055,114 1,347,106
Restricted cash 104,215 150
Property and equipment, net 136,813 145,096
Right-of-use assets, net 142,265 157,616
Intangible assets, net 6,760 8,979
Goodwill 3,290 3,290
Other assets, net 37,152 124,184
Total Assets 1,485,609 1,786,421
Current liabilities:    
Accounts payable 38,551 51,741
Accrued compensation 83,219 72,736
Accrued expenses 68,345 63,475
Deferred revenue 35,468 17,965
Total current liabilities 225,583 205,917
Convertible senior notes, net 1,142,547 1,139,966
Long-term operating lease liabilities 164,292 185,848
Other long-term liabilities 92,834 96,006
Total Liabilities 1,625,256 1,627,737
Commitments and contingencies
Stockholders’ equity (deficit):    
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and 2023 0 0
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of December 31, 2024 and 2023; 123,994,006 and 121,629,861 shares issued and outstanding as of December 31, 2024 and 2023, respectively 1 1
Additional paid-in capital 2,443,788 2,304,220
Accumulated other comprehensive loss (5,201) (3,675)
Accumulated deficit (2,578,235) (2,141,862)
Total Stockholders’ Equity (Deficit) (139,647) 158,684
Total Liabilities and Stockholders’ Equity (Deficit) $ 1,485,609 $ 1,786,421